Kinaxis and Tosoh Corporation Formulate an AI-Powered Supply Chain Transformation
'Kinaxis is excited to expand our footprint in the global chemical sector with Tosoh Corporation as they transform their supply chain operations and build market resilience,' said Masa Kogure, president, Japan at Kinaxis.
Share
As one of the largest chlor-alkali manufacturers in Asia, Tosoh supplies an array of basic and organic chemicals. From petrochemical operations that supply ethylene, polymers, and polyethylene, to its advanced materials business that serves the global semiconductor, display, and solar industries; even minor disruptions can have negative ripple effects across the supply chain.
Tosoh selected the Kinaxis Maestro™ platform for its unique ability to provide end-to-end orchestration that will strengthen coordination between sales and operations, optimize inventory, and improve supply and demand balancing, while navigating industry volatility. Historically reliant on spreadsheet-based manual processes, Tosoh faced significant challenges achieving visibility across its global operations. With Maestro, they now gain a powerful, unified platform that replaces fragmented workflows with intelligent automation, enabling faster, more sophisticated, data-driven decisions.
'We're excited to be working with Kinaxis to enhance and transform our supply chain operations,' said Mitsuhiro Nishimura, vice president at Tosoh Corporation. 'Traditional Enterprise Resource Planning systems simply can't keep up with the complexity and speed required in today's chemical industry, and Maestro will allow us to navigate industry challenges with greater resilience while advancing business growth and performance.'
'Kinaxis is excited to expand our footprint in the global chemical sector with Tosoh Corporation as they transform their supply chain operations and build market resilience,' said Masa Kogure, president, Japan at Kinaxis. 'Maestro will drive efficiency, agility and growth across their global operations with the visibility and speed needed to plan for and avoid disruptions, which are frequent across the complex chemical industry.'
To learn more about Kinaxis and its supply chain orchestration solutions, please visit Kinaxis.com
About Kinaxis
Kinaxis is a global leader in modern supply chain orchestration, powering complex global supply chains and supporting the people who manage them, in service of humanity. Our powerful, AI-infused supply chain orchestration platform, Maestro™, combines proprietary technologies and techniques that provide full transparency and agility across the entire supply chain — from multi-year strategic planning to last-mile delivery. We are trusted by renowned global brands to provide the agility and predictability needed to navigate today's volatility and disruption. For more news and information, please visit kinaxis.com or follow us on LinkedIn.
Source: Kinaxis Inc.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
an hour ago
- Yahoo
Why This Tech Stock Could Be the Next Shopify
Written by Amy Legate-Wolfe at The Motley Fool Canada Shopify (TSX:SHOP) is often the gold standard when it comes to Canadian tech success. It went from a little-known e-commerce company to one of the biggest stories on the TSX. So whenever a new name comes up with similar growth potential, it's worth paying attention. That's why (TSXV:TOI) is starting to get noticed. It doesn't have the flash of Shopify, but it has been quietly building something impressive. And for long-term investors, it could be one of the most exciting tech stocks on the market today. Topicus is a software company that focuses on vertical markets. That means it develops and acquires software tailored to specific industries like healthcare, education, and government. It's not trying to be everything to everyone. Instead, it wants to dominate smaller segments by offering exactly what those users need. This model allows it to grow quickly and maintain sticky customer relationships, since these tools are often deeply embedded into a company's day-to-day operations. The tech stock was spun out of Constellation Software in early 2021, and it has inherited some of the same strengths. Like its parent, Topicus is all about acquisition-led growth. It buys up smaller software firms, integrates them into its structure, and uses that foundation to continue growing. This buy-and-build strategy has worked well for Constellation, and Topicus is following a similar path. As of its latest report for the first quarter of 2025, Topicus posted revenue of €506 million, which is about $556 million in Canadian dollars. That was up from €451 million the year before. Net income came in at $37.4 million, with earnings per share (EPS) of $0.47. The tech stock continues to reinvest in operations and acquisitions, which can pressure short-term earnings but support long-term value creation. What makes Topicus exciting is its consistency. Over the past five years, it has grown earnings by 46% per year and revenues by 22% annually. Its return on equity sits at a strong 22.4%, and its profit margin is around 7.3%. Those are healthy numbers for a company in growth mode. These show it isn't just burning cash to expand. It's building a sustainable business with real profits and strong cash flow. The tech stock trades at a high valuation at about 93 times trailing earnings. That might scare off some investors, but it reflects the market's belief in Topicus' growth potential. Its market cap has now reached $22.7 billion, which is impressive for a tech stock still listed on the TSX Venture Exchange. There are risks, of course. The tech stock is highly acquisitive, so it depends on finding good businesses to buy at reasonable prices. Integration risk is real. If one of its acquisitions underperforms or doesn't mesh well with the rest of the business, it could drag down results. Macroeconomic issues in Europe, where many of its customers are located, could also impact demand. Still, Topicus has shown it can handle these challenges. Its focus on vertical markets gives it a defensive edge. Even during tough times, many of its customers can't easily switch to another provider. The software is too deeply ingrained in their daily operations. That helps keep revenue steady and allows Topicus to continue scaling over time. It might not become the next Shopify in terms of market cap, but Topicus has a real chance to become a dominant force in its own space. It's already proving that growth and profitability can go hand in hand. For investors looking for a Canadian tech stock with a long runway ahead, Topicus is a name to watch. And maybe, just maybe, it's the next big thing. The post Why This Tech Stock Could Be the Next Shopify appeared first on The Motley Fool Canada. Before you buy stock in Constellation Software, consider this: The Motley Fool Stock Advisor Canada analyst team just identified what they believe are the Top Stocks for 2025 and Beyond for investors to buy now… and Constellation Software wasn't one of them. The Top Stocks that made the cut could potentially produce monster returns in the coming years. Consider MercadoLibre, which we first recommended on January 8, 2014 ... if you invested $1,000 in the 'eBay of Latin America' at the time of our recommendation, you'd have $24,927.94!* Stock Advisor Canada provides investors with an easy-to-follow blueprint for success, including guidance on building a portfolio, regular updates from analysts, and two new stock picks each month – one from Canada and one from the U.S. The Stock Advisor Canada service has outperformed the return of S&P/TSX Composite Index by 30 percentage points since 2013*. See the Top Stocks * Returns as of 6/23/25 More reading Made in Canada: 5 Homegrown Stocks Ready for the 'Buy Local' Revolution [PREMIUM PICKS] Market Volatility Toolkit Best Canadian Stocks to Buy in 2025 Beginner Investors: 4 Top Canadian Stocks to Buy for 2025 5 Years From Now, You'll Probably Wish You Grabbed These Stocks Subscribe to Motley Fool Canada on YouTube Fool contributor Amy Legate-Wolfe has no position in any of the stocks mentioned. The Motley Fool has positions in and recommends Shopify and The Motley Fool recommends Constellation Software. The Motley Fool has a disclosure policy. 2025 Effettua l'accesso per consultare il tuo portafoglio
Los Angeles Times
3 hours ago
- Los Angeles Times
Vera Clinic Becomes Official Hair Transplant Partner of the Houston Rockets
Vera Clinic, Europe's leading center for hair transplantation and regenerative medicine, is now the official hair transplant partner of the Houston Rockets, one of the most iconic members of the National Basketball Association (NBA). Launching in July 2025 and continuing throughout the 2025-2026 NBA season, this collaboration marks a milestone in connecting elite healthcare with elite sports. This is more than a partnership. This is about trust. This is about quality. This is about showing the world what happens when science, innovation, and ethics unite on a global stage. Sport and medicine seem worlds apart. But at the highest level, they speak the same language: precision, perfection and performance. This alliance is built on a shared mission: ✔️ To lead with integrity ✔️ To perform at the highest level ✔️ To earn global trust, one result at a time 'This powerful alliance is a statement of trust. Just as athletes depend on consistency and excellence, so do Vera Clinic's patients,' said a spokesperson from the Houston Rockets. 'We're proud to welcome them as an official partner and look forward to building a shared story of excellence and trust.' 'Partnering with the Houston Rockets is a reflection of what we've built over the last decade,' said Kazım Sipahi, founder of Vera Clinic.'From day one, we've prioritized transparency, science, and ethical care. To be acknowledged by an institution like the Rockets means our standard is global.' Vera Clinic was awarded the prestigious European Medicine Award for its commitment to clinical transparency, innovation, and patient-centered care. With over 40,000 patients from more than 80 countries, it has become a global destination for those seeking natural-looking hair restoration, built on real procedures, advanced technology and innovative techniques that consistently deliver beyond expectations. At the Houston Rockets, we know that trust isn't given – it's built. Game by game. Season by season. And Vera Clinic operates the same way: with relentless discipline, medical transparency and proven outcomes that stand the test of time. Founded in Istanbul, Türkiye Vera Clinic is a multi-award-winning medical center specializing in hair transplantation, with a special focus on personalized solutions, high-density grafting, and natural-looking results. The clinic has been featured in the Reuters, USA Today, Bustle and international rankings, and is known for its 18-month growth guarantee and patient-centered approach. Vera Clinic founded Sapphire FUE and created Oxycure™ Therapy – setting new standards in hair restoration with faster recovery, real science, and results trusted worldwide. Backed by Science. Endorsed by Champions Let the world see what trust looks like! Address: Kordonboyu, Turgut Özal Blv. No: 47,34860 Kartal/İ @veraclinicFacebook: @VeraClinicYouTube: @VeraClinicTikTok: @veraclinicWhatsApp: +90 555 888 81 23
Business Wire
4 hours ago
- Business Wire
Accord Announces Voting Results of Annual Meeting
TORONTO--(BUSINESS WIRE)--Accord Financial Corp. (TSX – ACD) (the 'Company') today announced the voting results from its Annual Meeting of Shareholders ('AGM') held on May 14, 2025 in Toronto, Ontario. The results were reported at the AGM, however, the announcement and filing were inadvertently delayed. Shareholders voted in favour of all items of business put forth at the meeting as set out below. A total of 6,406,657 shares were represented at the AGM representing 74.85% of the total issued and outstanding shares. 1. Election of Directors The following seven nominees were elected to serve as directors of the Company until the next annual meeting of shareholders or until their successors are elected or appointed: Number of Votes Percentage of Votes Cast Name For Withheld For Withheld David Beutel 6,105,873 300,599 95.31% 4.69% Burt Feinberg 5,836,773 569,699 91.11% 8.89% Simon Hitzig 5,798,373 608,099 90.51% 9.49% Jean Holly 5,853,373 553,099 91.37% 8.63% Gary Prager 5,829,873 576,599 91.00% 9.00% David Spivak 5,813,273 593,199 90.74% 9.26% Stephen Warden 5,836,773 569,699 91.11% 8.89% Expand 2. Appointment of Auditors KPMG LLP, Chartered Professional Accountants, was appointed as auditors of the Company for the fiscal year ending December 31, 2025. For Withheld For Withheld 6,391,547 15,110 99.76% 0.24% Expand About Accord Financial Corp. Accord Financial is one of North America's most dynamic commercial finance companies providing fast, versatile financing solutions including asset-based lending, factoring, inventory finance, equipment finance (in Canada), trade finance and film/media finance. By leveraging our unique combination of financial strength, deep experience and independent thinking, we craft winning financial solutions for small and medium-sized businesses, simply delivered, so our clients can thrive.
